Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024

[anonymous]

That’s about 19 million USD boys and girls.

Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024

Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024

 

[anonymous]

20 million in the first quarter of launch in Japan. Pretty good I think considering the diagnostic process and it got approved in Japan in November. I bet we did that in the month of April sales $$$ for Leq in the US.

 

[anonymous]

That’s about 19 million USD boys and girls.

Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024

Leqembi® revenue totaled JPY 2.83 billion in the first quarter 2024

Pathetic performance

 

[anonymous]

Eisai US was created to manage two copromote relationships—Pfizer and J&J—where the partners did 80% - 90% of the work. It’s never really evolved beyond that.

 

[anonymous]

With co promotes, jobs are secured. As soon as my year is up.... out of here

 

[anonymous]

With co promotes, jobs are secured. As soon as my year is up.... out of here

No one should waste their career at Eisai.

 

[anonymous]

Your company sucks, all I hear is complaints about your reps.

 

[anonymous]

Alex Scott did the dude.

 

[anonymous]

Eisai is shit.

 

[anonymous]

The benefit is questionable. The danger is real.